Annual Total Expenses
$261.08 M
+$2.72 M+1.05%
31 December 2023
Summary:
AbCellera Biologics annual total expenses is currently $261.08 million, with the most recent change of +$2.72 million (+1.05%) on 31 December 2023. During the last 3 years, it has risen by +$192.27 million (+279.45%). ABCL annual total expenses is now at all-time high.ABCL Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$96.68 M
-$788.00 K-0.81%
30 September 2024
Summary:
AbCellera Biologics quarterly total expenses is currently $96.68 million, with the most recent change of -$788.00 thousand (-0.81%) on 30 September 2024. Over the past year, it has increased by +$38.02 million (+64.81%). ABCL quarterly total expenses is now -0.81% below its all-time high of $97.47 million, reached on 30 June 2024.ABCL Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABCL Total Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +1.1% | +64.8% |
3 y3 years | +279.4% | +230.8% |
5 y5 years | +3167.6% | - |
ABCL Total Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +279.4% | -0.8% | +230.8% |
5 y | 5 years | at high | +3167.6% | -0.8% | +2184.5% |
alltime | all time | at high | +3167.6% | -0.8% | +2184.5% |
AbCellera Biologics Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $96.68 M(-0.8%) |
June 2024 | - | $97.47 M(+58.3%) |
Mar 2024 | - | $61.57 M(-14.3%) |
Dec 2023 | $261.08 M(+1.1%) | $71.86 M(+22.5%) |
Sept 2023 | - | $58.66 M(+3.2%) |
June 2023 | - | $56.87 M(-22.8%) |
Mar 2023 | - | $73.69 M(+27.8%) |
Dec 2022 | $258.36 M | $57.65 M(-6.3%) |
Sept 2022 | - | $61.50 M(+16.5%) |
June 2022 | - | $52.78 M(-38.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $86.44 M(+64.7%) |
Dec 2021 | $153.30 M(+122.8%) | $52.47 M(+79.5%) |
Sept 2021 | - | $29.22 M(-2.7%) |
June 2021 | - | $30.03 M(-27.7%) |
Mar 2021 | - | $41.52 M(-15.3%) |
Dec 2020 | $68.80 M(+393.0%) | $49.03 M(+400.7%) |
Sept 2020 | - | $9.79 M(+131.4%) |
June 2020 | - | $4.23 M(-26.4%) |
Mar 2020 | - | $5.75 M(+23.8%) |
Dec 2019 | $13.96 M(+74.7%) | $4.64 M |
Dec 2018 | $7.99 M | - |
FAQ
- What is AbCellera Biologics annual total expenses?
- What is the all time high annual total expenses for AbCellera Biologics?
- What is AbCellera Biologics annual total expenses year-on-year change?
- What is AbCellera Biologics quarterly total expenses?
- What is the all time high quarterly total expenses for AbCellera Biologics?
- What is AbCellera Biologics quarterly total expenses year-on-year change?
What is AbCellera Biologics annual total expenses?
The current annual total expenses of ABCL is $261.08 M
What is the all time high annual total expenses for AbCellera Biologics?
AbCellera Biologics all-time high annual total expenses is $261.08 M
What is AbCellera Biologics annual total expenses year-on-year change?
Over the past year, ABCL annual total expenses has changed by +$2.72 M (+1.05%)
What is AbCellera Biologics quarterly total expenses?
The current quarterly total expenses of ABCL is $96.68 M
What is the all time high quarterly total expenses for AbCellera Biologics?
AbCellera Biologics all-time high quarterly total expenses is $97.47 M
What is AbCellera Biologics quarterly total expenses year-on-year change?
Over the past year, ABCL quarterly total expenses has changed by +$38.02 M (+64.81%)